{"entity":{"type":"insider","cik":"0001838044","url":"/insider/0001838044","json_url":"/insider/0001838044.json","name":"Petrova Penka","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2021-01-11","last":"2021-04-09","span_basis":"filed_date"},"name_variants":[{"name":"Petrova Penka","source":"filing","n_filings":6,"first_seen":"2021-01-11","last_seen":"2021-04-09"}],"transactions":[{"id":4614900,"accession":"0001062993-21-003541","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-21-003541","line_url":"/filing/0001062993-21-003541#line-3","is_derivative":false,"issuer_cik":"0001616212","issuer_name":"Trillium Therapeutics Inc.","issuer_ticker":"TRIL","issuer_name_source":null,"issuer_url":"/issuer/0001616212","owner_cik":"0001838044","owner_name":"Petrova Penka","owner_display_name":"Petrova Penka","owner_url":"/insider/0001838044","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5312.0,"shares_display":"5,312","price_per_share":11.09,"price_display":"11.09","price_state":"stated","total_value":58910.08,"total_display":"58,910.08","total_whole":"58,910","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-08","filed_date":"2021-04-09","scope":"insider"},{"id":4614876,"accession":"0001062993-21-002674","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-21-002674","line_url":"/filing/0001062993-21-002674#line-3","is_derivative":false,"issuer_cik":"0001616212","issuer_name":"Trillium Therapeutics Inc.","issuer_ticker":"TRIL","issuer_name_source":null,"issuer_url":"/issuer/0001616212","owner_cik":"0001838044","owner_name":"Petrova Penka","owner_display_name":"Petrova Penka","owner_url":"/insider/0001838044","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5312.0,"shares_display":"5,312","price_per_share":11.08,"price_display":"11.08","price_state":"stated","total_value":58856.96,"total_display":"58,856.96","total_whole":"58,857","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-10","filed_date":"2021-03-12","scope":"insider"},{"id":5528734,"accession":"0001062993-21-001199","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001062993-21-001199","line_url":"/filing/0001062993-21-001199#line-5","is_derivative":false,"issuer_cik":"0001616212","issuer_name":"Trillium Therapeutics Inc.","issuer_ticker":"TRIL","issuer_name_source":null,"issuer_url":"/issuer/0001616212","owner_cik":"0001838044","owner_name":"Petrova Penka","owner_display_name":"Petrova Penka","owner_url":"/insider/0001838044","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":508.0,"shares_display":"508","price_per_share":14.174,"price_display":"14.17","price_state":"stated","total_value":7200.392,"total_display":"7,200.39","total_whole":"7,200","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-10","scope":"insider"},{"id":5528729,"accession":"0001062993-21-001199","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-21-001199","line_url":"/filing/0001062993-21-001199#line-3","is_derivative":false,"issuer_cik":"0001616212","issuer_name":"Trillium Therapeutics Inc.","issuer_ticker":"TRIL","issuer_name_source":null,"issuer_url":"/issuer/0001616212","owner_cik":"0001838044","owner_name":"Petrova Penka","owner_display_name":"Petrova Penka","owner_url":"/insider/0001838044","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5312.0,"shares_display":"5,312","price_per_share":12.65,"price_display":"12.65","price_state":"stated","total_value":67196.8,"total_display":"67,196.80","total_whole":"67,197","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-10","scope":"insider"},{"id":5241454,"accession":"0001062993-21-000339","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-21-000339","line_url":"/filing/0001062993-21-000339#line-2","is_derivative":false,"issuer_cik":"0001616212","issuer_name":"Trillium Therapeutics Inc.","issuer_ticker":"TRIL","issuer_name_source":null,"issuer_url":"/issuer/0001616212","owner_cik":"0001838044","owner_name":"Petrova Penka","owner_display_name":"Petrova Penka","owner_url":"/insider/0001838044","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":508.0,"shares_display":"508","price_per_share":15.2073,"price_display":"15.21","price_state":"stated","total_value":7725.3084,"total_display":"7,725.31","total_whole":"7,725","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-13","scope":"insider"},{"id":5139566,"accession":"0001062993-21-000289","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-21-000289","line_url":"/filing/0001062993-21-000289#line-2","is_derivative":false,"issuer_cik":"0001616212","issuer_name":"Trillium Therapeutics Inc.","issuer_ticker":"TRIL","issuer_name_source":null,"issuer_url":"/issuer/0001616212","owner_cik":"0001838044","owner_name":"Petrova Penka","owner_display_name":"Petrova Penka","owner_url":"/insider/0001838044","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2604.0,"shares_display":"2,604","price_per_share":15.501,"price_display":"15.50","price_state":"stated","total_value":40364.604,"total_display":"40,364.60","total_whole":"40,365","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-08","filed_date":"2021-01-12","scope":"insider"},{"id":4455799,"accession":"0001062993-21-000265","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-21-000265","line_url":"/filing/0001062993-21-000265#line-2","is_derivative":false,"issuer_cik":"0001616212","issuer_name":"Trillium Therapeutics Inc.","issuer_ticker":"TRIL","issuer_name_source":null,"issuer_url":"/issuer/0001616212","owner_cik":"0001838044","owner_name":"Petrova Penka","owner_display_name":"Petrova Penka","owner_url":"/insider/0001838044","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2708.0,"shares_display":"2,708","price_per_share":14.713,"price_display":"14.71","price_state":"stated","total_value":39842.804,"total_display":"39,842.80","total_whole":"39,843","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-07","filed_date":"2021-01-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001616212","name":"Trillium Therapeutics Inc.","url":"/issuer/0001616212","role":"Officer (Chief Development Officer)","n_filings":6,"first_seen":"2021-01-11","last_seen":"2021-04-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001838044","retrieved_at":"2026-08-22T05:55:51+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}